Neuroprotection Market 2028 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

report image

Neuroprotection Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Free Radical Trapping Agents (Antioxidants), Apoptosis Inhibitors, Anti-inflammatory Agents, Glutamate Antagonists (Anti-Excitotoxic Agents), Metal Ion Chelators and Others), Application (Treatment and Prevention) and Geography

Report Code: TIPMD00002291 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries among others. Neuroprotective agents in clinical pipelines comprise small-molecule drugs, gene and cell therapies, therapeutic monoclonal antibodies and other agents

The neuroprotection market of is expected to grow with a significant rate in the forecast years, owing to driving factors such as, growing drug development in the pharmaceutical and biotechnology industry along with increasing patient population pool, rising incidences of CNS diseases, increased demand for more target specific drug treatment for neurodegenerative diseases with favorable government regulations. The increasing healthcare infrastructure, increasing economic stability in developing economies, are likely to offer more opportunities in the neuroprotection market.

The “Global Neuroprotection Market Analysis To 2028” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuroprotection market with detailed market segmentation by product, application and geography. The global neuroprotection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Neuroprotection market.

The global neuroprotection market is segmented on the basis of product and application. Based on product, the neuroprotection market has been segmented into free radical trapping agents (antioxidants), apoptosis inhibitors, anti-inflammatory agents, glutamate antagonists (anti-excitotoxic agents), metal ion chelators and others. The application segment is classified as treatment and prevention.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuroprotection market based on product, application and geography. It also provides market size and forecast till 2028 for overall neuroprotection market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the neuroprotection market in the coming years, owing to factors such as, various market players operate in this region. The European region is expected to hold the second largest market for the neuroprotection. Asia Pacific is anticipated to be the fastest growing market as the due to the growing number of the neurological disorders in the countries, effect of pricing pressure due to grown competition amongst important brands, rise of generic products and growing number of regional players who are able to provide products at much lower prices.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key neuroprotection market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Eli Lilly and Company, Allergan plc, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Novartis AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Biogen Inc., Astrocyte Pharmaceuticals, Inc. and other prominent players.
The List of Companies

1. Eli Lilly and Company
2. Allergan plc
3. Dr. Reddy’s Laboratories Ltd.
4. Teva Pharmaceutical Industries Ltd.
5. Daiichi Sankyo Company
6. Novartis AG
7. F. Hoffmann-La Roche AG
8. AstraZeneca plc
9. Biogen Inc.
10. Astrocyte Pharmaceuticals, Inc.
TIPMD00002291
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount